Higher levels of dengue-virus-specific IgG and IgA during pre-defervescence associated with primary dengue hemorrhagic fever

Dengue and severe dengue (Fact sheet N°117) (2013): WHO Media Centre, updated September. http://www.who.int/factsheets

WHO (2009) Dengue Guidelines for diagnosis, treatment, prevention and control. WHO, Geneva (new edition)

de Alwis R, Beltramello M, Messer WB, Sukupolvi-Petty S, Wahala WM, Kraus A et al (2011) In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection. PLoS Negl Trop Dis 5:e1188

Clyde K, Kyle JL, Harris E (2006) Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol 80:11418–11431

Ngwe Tun MM, Thant KZ, Inoue S, Kurosawa Y, Lwin YY, Lin S et al (2013) Serological characterization of dengue virus infections observed among dengue hemorrhagic fever/dengue shock syndrome cases in upper Myanmar. J Med Virol 85:1258–1266

Costa VV, Fagundes CT, Souza DG, Teixeira MM (2013) Inflammatory and innate immune responses in dengue infection: protection versus disease induction. Am J Pathol 182:1950–1956

Halstead SB (2003) Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 60:421–467

García G, Arango M, Pérez AB, Fonte L, Sierra B, Rodríguez-Roche R et al (2006) Antibodies from patients with dengue viral infection mediate cellular cytotoxicity. J Clin Virol 37:53–57

Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W et al (2010) Cross-reacting antibodies enhance dengue virus infection in humans. Science 328:745–748

Lin YS, Yeh TM, Lin CF, Wan SW, Chuang YC, Hsu TK et al (2011) Molecular mimicry between virus and host and its implications for dengue disease pathogenesis. Exp Biol Med (Maywood) 236:515–523

Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, Auethavornanan K et al (2006) Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis 193:1078–1088

Nascimento EJM, Silva AM, Cordeiro MT, Brito CA, Gil LH, Braga-Neto U et al (2009) Alternative complement pathway deregulation is correlated with dengue severity. PLoS ONE 4:e6782

Bokisch VA, Muller-Eberhard HJ, Dixon FJ (1973) The role of complement in hemorrhagic shock syndrome (dengue). Trans Assoc Am Physicians 86:102–110

Bruggemann M, Williams GT, Bindon CI, Clark MR, Walker MR, Jefferis R et al (1987) Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med 166:1351–1361

Koraka P, Suharti C, Setiati TE, Mairuhu AT, Van Gorp E, Hack CE et al (2001) Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection. J Clin Microbiol 39:4332–4338

Koraka P, Murgue B, Deparis X, Setiati TE, Suharti C, van Gorp EC et al (2003) Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity. J Med Virol 70:91–98

Thein S, Aaskov J, Myint TT, Shwe TN, Saw TT, Zaw A (1993) Changes in levels of anti-dengue virus IgG subclasses in patients with disease of varying severity. J Med Virol 40:102–106

Vázquez S, Pérez AB, Ruiz D, Rodríguez R, Pupo M, Calzada N et al (2005) Serological markers during dengue 3 primary and secondary infections. J Clin Virol 33:132–137

Vazquez S, Lozano C, Perez AB, Castellanos Y, Ruiz D, Calzada N et al (2013) Dengue specific immunoglobulins M, A, and E in primary and secondary dengue 4 infected salvadorian children. J Med Virol. doi:10.1002/jmv.23833

Priyadarshini D, Gadia RR, Tripathy A, Gurukumar KR, Bhagat A, Patwardhan S et al (2010) Clinical findings and pro-inflammatory cytokines in dengue patients in western india: a facility-based study. PLoS ONE 5:e8709

Alagarasu K, Mulay AP, Singh R, Gawade VB, Shah PS, Cecilia D (2013) Association of HLA-DRB1 and TNF genotypes with dengue hemorrhagic fever. Hum Immunol 74:610–661

Alagarasu K, Mulay AP, Mohsen S, Rashmika D, Shah PS, Cecilia D (2013) Profile of human leukocyte antigen class I alleles in patients with dengue infection from Western India. Hum Immunol 74:1624–1628

Cecilia D (2014) Current status of dengue and chikungunya. WHO South-East Asia J Public Health 3:22–27

World Health Organisation (1999): Prevention and control of Dengue and Dengue haemorrhagic fever: Comprehensive guidelines. WHO Regional Publication SEARO No. 29, pp 11–19

Puschnik A, Lau L, Cromwell EA, Balmaseda A, Zompi S, Harris E (2013) Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans. PLoS Negl Trop Dis 7:e2274

Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S et al (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181:2–9

Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, Suntayakorn S et al (2002) Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 185:1213–1221

Falgout B, Bray M, Schlesinger JJ, Lai CJ (1990) Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis. J Virol 64:4356–4363

Laoprasopwattana K, Libraty DH, Endy TP, Nisalak A, Chunsuttiwat S, Ennis FA et al (2007) Antibody-dependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: potential involvement in early control of viral replication. J Infect Dis 195:1108–1116

Guzman MG, Alvarez M, Halstead SB (2013) Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol 158:1445–1459

De Rivera IL, Parham L, Murillo W, Moncada W, Vazquez S (2008) Humoral immune response of dengue hemorrhagic fever cases in children from Tegucigalpa, Honduras. Am J Trop Med Hyg 79:262–266

Yang YH, Huang YH, Lin YL, Wang LC, Chuang YH, Yu HH et al (2006) Circulating IgA from acute stage of childhood Henoch-Schönlein purpura can enhance endothelial interleukin (IL)-8 production through MEK/ERK signalling pathway. Clin Exp Immunol 144:247–253

Upadhaya BK, Sharma A, Khaira A, Dinda AK, Agarwal SK, Tiwari SC (2010) Transient IgA nephropathy with acute kidney injury in a patient with dengue fever. Saudi J Kidney Dis Transpl 21:521–525

Boesiger J, Tsai M, Maurer M, Yamaguchi M, Brown LF, Claffey KP et al (1998) Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression. J Exp Med 188:1135–1145

Borish L, Mascali JJ, Rosenwasser LJ (1991) IgE-dependent cytokine production by human peripheral blood mononuclear phagocytes. J Immunol 146:63–67

Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS (2000) Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol 28:183–188

Mosmann TR, Sad S (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138–146